FDA clears expansion of Creative Medical's back pain trial
Tweet Send to a Friend
Creative Medical Technology Holdings (NASDAQ: CELZ) announced that the U.S. Food and Drug Administration has cleared an expansion of its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


